[Menopausal hormonal therapy and cancer risks].

Gynecologie, obstetrique & fertilite

PubMedID: 27451070

Lasserre A, Fournier A. [Menopausal hormonal therapy and cancer risks]. Gynecol Obstet Fertil. 2016;44(7-8):424-7.
Estrogen-progestagen menopausal hormonal therapy (MHT) is recognized as carcinogenic to humans. The article presents the associations between MHT and breast, ovary and endometrial cancer risks, in particular according to treatment modalities. If MHT must be prescribed, it is recommended to use the lowest dose for the shortest possible duration. Discussing with the patient the benefits but also the risks and making regular gynecological follow-up are strongly encouraged.